DementiaAATPDNCT03946696
Animal-Assisted Therapy for People With Dementia
An observational study of Dementia, run by University of Aberdeen at 1 site in United Kingdom.
Trial summary
This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. Read more about this study
- Who is it for?
- Ages 55 to 100 years
- Conditions the study is for
- Dementia
- What is being tested?
- Interactions with therapy-animals
- How many people
- 20 participants
- Where
- 1 siteUnited Kingdom
- Study dates
- 15 Jan 2022to 31 Dec 2022
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 55 to 100 years
- All sexes
- Adult, Older adult
Study population: People with moderate and severe dementia living in a care home; who are visited by therapy-animal teams.
Who may be able to join
- People diagnosed with moderate and severe dementia living in a nursing home, age range 55-100.
- The above-mentioned participants who receive therapy-animal services.
Who cannot join
- People with other medical conditions who receive visits from therapy-animals and who do not reside in a care home.
- People with dementia who do not reside in a care home.
- People with dementia younger than 55 years old who live in their own home.
Trial locations and contacts
1 site in 1 country.
United Kingdom1 site
University of Aberdeen
Aberdeen, Aberdeenshire, AB25 2ZB
About this study
Official title: Bonding at the Very End Emerging Personhood During End-of-life and Palliative Care Through Animal-Assisted Therapy (AAT)
This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.
This study does not test hypotheses.
Read the detailed description
This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.
AAT is defined as an activity provided by a handler and his/her animal (e.g., dog, cat, rabbit, bird, horse) for somebody living with a certain medical condition/illness. AAT is different than Assistant Dogs/Animal (e.g., guide dogs for the blind), who have a very specific training. In this research, we will focus mostly on therapy-dogs and therapy-owls for people with dementia living in care homes.
The research will be conducted over a period of 12 months. The primary methods that will be used are participant observation (accompanying and observing volunteers during animal-assisted therapy meetings and various activities in the care homes) and interviewing the residents, care homes' staff, volunteers, canine trainers and veterinarians. Additional data will be collected through document analysis (consulting care home policies and participants' care plans and medical notes) and auto-ethnography (auto-observations of interactions between the student and 2 dogs).
The instruments described in the outcome measures are used as guidance only. As this research is non-quantitative, the items listed in the scale instruments are not administered like in a usual clinical testing. The specificity of anthropological research, especially in regard to the use of its methods (participant observation, triangulated with in-depth interview, document analysis and auto-ethnography) addresses implicitly the limitations of such instruments.
While the focus of the research remains on the interactions between people with dementia and therapy-animals, the involvement of the other participants offers different perspectives of looking at these interactions and at their context. For anthropological research, it is fundamental that a certain topic/issue is addressed in its context by gathering information from multiple perspectives. This has been documented as being one of the biggest strengths of anthropological research investigating a clinical-related topic.
The aim of this research is to understand what are the effects that therapy-animals can have on people living with dementia (in moderate and severe stages) in a care facility. While it doesn't aim to compare people living with dementia in their own homes and their potential interaction with a therapy-animal, the research compares the effects of AAT with other activities (e.g., music therapy; craft therapy) and in the context of human interactions (e.g., interactions with other residents; care facility staff members; family members). Because it is documented that animals' therapeutic effects are possible through bond transference, the research also looks as part of the context at how the human-animal bond is formed, how can be transferred and how participants may develop a bond with the therapy-animal. This will be done by interviewing therapy-animal volunteers; canine trainers; and veterinarians. While these might appear as two different projects, we argue that this perspective (how the human-animal bond is formed and its potential therapeutic effect in being transferred) can offer new and original insights in understanding dementia and its stages, as well as a more accurate understanding of AAT effects on people with moderate and severe dementia.
Although the benefits of Animal-Assisted Therapy have been previously documented, these were mostly statistical or experimental studies. To date, there is no study that explores the relationship between therapy-animals and people with dementia using a long-term qualitative approach. Almost all the studies consulted in preparation for our protocol recommend a research that approaches AAT for people with dementia in the context of social interactions and living conditions and from the perspectives described by us. The lack of the context and of these perspectives have been documented/acknowledged as limitations of previous studies in understanding the effects of AAT for people with dementia. These limitations are addressed in our study by looking at them from the diversity of the perspectives we propose.
Given the increased number of people living with dementia, the moral imperative of offering them activities that enhance their quality of life especially in later stages, as well as the rising literature documenting the benefits of companion animals, we aim that this research to contribute to new approaches and policies of care for people with moderate and severe dementia.
- Conditions
- Dementia
- Being tested
- Interactions with therapy-animals
- Keywords
- dementia, Animal-Assisted Therapy, ethnography, qualitative study
- Medical subject headings
- Dementia
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Interactions with therapy-animalsOther
How people interact with humans and non-humans animals during and outside visits from therapy-animal teams.
| Study group | Role | What they receive |
|---|---|---|
| Dementia | Observations of communication and interactions between people with dementia living in a care home and therapy-animals. Receives: Other: Interactions with therapy-animals |
What is being measured
The primary outcome is the main question the study is designed to answer.
Behavioural and Psychological Symptoms of Dementia (BPSD)
Observations of behaviours associated with dementia (wandering; agitation; anxiety; irritability; apathy; disinhibition). Please note this is a qualitative study that does not use measuring tools.
Measured: 12 months
Symptoms of Depression in dementia
Observation - Please note this is a qualitative study that does not use measuring tools.
Measured: 12 months
Verbal and non-verbal aspects of communication in dementia (e.g., smile; touch; direction of gaze); words.
Observations and interviews - Please note this is a qualitative study that does not use measuring tools.
Measured: 12 months
Secondary outcomes (1)
Patient experience of Animal-Assisted Therapy visits
Qualitative evaluation of patient experience of visits from a therapy-animal team assessed in qualitative in-depth interviews.
Measured: 15 minutes-1 hour
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted13 May 2019
- Study start15 Jan 2022
- Primary completion31 Dec 2022
- Study completion31 Dec 2022
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for DementiaStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 20 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of Aberdeen
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
- Investigators
- Andrew Whitehouse, Principal investigator, University of Aberdeen
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT03946696
- Sponsor's protocol ID
- 2-097-18
- Acronym
- AATPD
- Status last verified
- Jan 2022
- First submitted
- 29 Oct 2018
- Last updated
- 14 May 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No: Only the main researcher Cristina Douglas will have access to primary data.
Study at a glance
From the registry record, last updated by the sponsor on 14 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Bonding at the Very End Emerging Personhood During End-of-life and Palliative Care Through Animal-Assisted Therapy (AAT)
- ClinicalTrials.gov ID
- NCT03946696
- Acronym / sponsor ID
- AATPD / 2-097-18
- Conditions
- Dementia
- Keywords
- dementia, Animal-Assisted Therapy, ethnography, qualitative study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 20 participants (actual)
- Lead sponsor
- University of AberdeenUniversity, hospital or other
- Study start
- 15 Jan 2022 (actual)
- Primary completion
- 31 Dec 2022 (actual)
- Study completion
- 31 Dec 2022 (actual)
- First posted
- 13 May 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.
This study does not test hypotheses.
Detailed description
This study is a qualitative anthropological research that explores the effects of Animal-Assisted Therapy (AAT) for people with moderate and severe dementia living in a care facility. In particular, the study explores the effects that AAT can have on people with moderate and later stages of dementia, living in a care facility, on: Behavioural and Psychological Symptoms of Dementia (BPSD); mood (depression); quality of life; activity (physical). The AAT effects on people with moderate and later stages of dementia will be compared with effects that other activities provided in the care facility where participants live, may have on the same participants.
AAT is defined as an activity provided by a handler and his/her animal (e.g., dog, cat, rabbit, bird, horse) for somebody living with a certain medical condition/illness. AAT is different than Assistant Dogs/Animal (e.g., guide dogs for the blind), who have a very specific training. In this research, we will focus mostly on therapy-dogs and therapy-owls for people with dementia living in care homes.
The research will be conducted over a period of 12 months. The primary methods that will be used are participant observation (accompanying and observing volunteers during animal-assisted therapy meetings and various activities in the care homes) and interviewing the residents, care homes' staff, volunteers, canine trainers and veterinarians. Additional data will be collected through document analysis (consulting care home policies and participants' care plans and medical notes) and auto-ethnography (auto-observations of interactions between the student and 2 dogs).
The instruments described in the outcome measures are used as guidance only. As this research is non-quantitative, the items listed in the scale instruments are not administered like in a usual clinical testing. The specificity of anthropological research, especially in regard to the use of its methods (participant observation, triangulated with in-depth interview, document analysis and auto-ethnography) addresses implicitly the limitations of such instruments.
While the focus of the research remains on the interactions between people with dementia and therapy-animals, the involvement of the other participants offers different perspectives of looking at these interactions and at their context. For anthropological research, it is fundamental that a certain topic/issue is addressed in its context by gathering information from multiple perspectives. This has been documented as being one of the biggest strengths of anthropological research investigating a clinical-related topic.
The aim of this research is to understand what are the effects that therapy-animals can have on people living with dementia (in moderate and severe stages) in a care facility. While it doesn't aim to compare people living with dementia in their own homes and their potential interaction with a therapy-animal, the research compares the effects of AAT with other activities (e.g., music therapy; craft therapy) and in the context of human interactions (e.g., interactions with other residents; care facility staff members; family members). Because it is documented that animals' therapeutic effects are possible through bond transference, the research also looks as part of the context at how the human-animal bond is formed, how can be transferred and how participants may develop a bond with the therapy-animal. This will be done by interviewing therapy-animal volunteers; canine trainers; and veterinarians. While these might appear as two different projects, we argue that this perspective (how the human-animal bond is formed and its potential therapeutic effect in being transferred) can offer new and original insights in understanding dementia and its stages, as well as a more accurate understanding of AAT effects on people with moderate and severe dementia.
Although the benefits of Animal-Assisted Therapy have been previously documented, these were mostly statistical or experimental studies. To date, there is no study that explores the relationship between therapy-animals and people with dementia using a long-term qualitative approach. Almost all the studies consulted in preparation for our protocol recommend a research that approaches AAT for people with dementia in the context of social interactions and living conditions and from the perspectives described by us. The lack of the context and of these perspectives have been documented/acknowledged as limitations of previous studies in understanding the effects of AAT for people with dementia. These limitations are addressed in our study by looking at them from the diversity of the perspectives we propose.
Given the increased number of people living with dementia, the moral imperative of offering them activities that enhance their quality of life especially in later stages, as well as the rising literature documenting the benefits of companion animals, we aim that this research to contribute to new approaches and policies of care for people with moderate and severe dementia.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Dementia | – | Other: Interactions with therapy-animalsObservations of communication and interactions between people with dementia living in a care home and therapy-animals. |
Who may qualify
- Ages
- 55 to 100 years
- Sex
- All
- Age groups
- Adult, Older adult
- Study population
- People with moderate and severe dementia living in a care home; who are visited by therapy-animal teams.
Key inclusion criteria (2 listed)
- People diagnosed with moderate and severe dementia living in a nursing home, age range 55-100.
- The above-mentioned participants who receive therapy-animal services.
Key exclusion criteria (3 listed)
- People with other medical conditions who receive visits from therapy-animals and who do not reside in a care home.
- People with dementia who do not reside in a care home.
- People with dementia younger than 55 years old who live in their own home.
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Interactions with therapy-animalsHow people interact with humans and non-humans animals during and outside visits from therapy-animal teams. | Other | Dementia |
Primary outcome
Behavioural and Psychological Symptoms of Dementia (BPSD)
Time frame: 12 months
Observations of behaviours associated with dementia (wandering; agitation; anxiety; irritability; apathy; disinhibition). Please note this is a qualitative study that does not use measuring tools.
Symptoms of Depression in dementia
Time frame: 12 months
Observation - Please note this is a qualitative study that does not use measuring tools.
Verbal and non-verbal aspects of communication in dementia (e.g., smile; touch; direction of gaze); words.
Time frame: 12 months
Observations and interviews - Please note this is a qualitative study that does not use measuring tools.
1 secondary outcome
Patient experience of Animal-Assisted Therapy visits
Time frame: 15 minutes-1 hour
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 14 May 2026.
- Individual participant dataSharing planned: No. Only the main researcher Cristina Douglas will have access to primary data.
Related trials for Dementia
RecruitingPhase 2
Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin
Alzheimer's Disease
Not yet recruiting
Acupressure as Long-term Intervention to Slow the Progression of Early/Mild Alzheimer's Disease
Alzheimer's Disease
RecruitingObservational study
Effectiveness and Safety of Disease-Modifying Therapy for Alzheimer's Disease: A Multicenter Retrospective Study
Alzheimer's Disease (AD)
Not yet recruitingPhase 2
Lisdexamfetamine For the Treatment of Conduct Disorder in Children
Conduct Disorder
RecruitingPhase 3
A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)
Alzheimer Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Andrew Whitehouse principal investigator
University of Aberdeen
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Dementia, run by University of Aberdeen at 1 site in United Kingdom.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 14 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in United Kingdom. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Behavioural and Psychological Symptoms of Dementia (BPSD) (time frame: 12 months). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 May 2026; AzTrials last refreshed its copy on 7 Nov 2026.